Agenda
Introduction and
Overview Meyer D. Glantz, Ph.D., National Institute
on Drug Abuse |
I. Basics
A research-based review of the epidemiology, neurobiology,
and risk factors for comorbid psychiatric and drug use disorders
in a developmental context.
Chair: Naimah Weinberg, M.D., National Insitute
on Drug Abuse
Presentation |
Presenters
|
Introduction to Basics |
Kathleen R. Merikangas,
Ph.D.
Yale University |
Developmental Epidemiology
Of Drug Abuse and Comorbidity |
Elizabeth Jane Costello,
Ph.D.
Duke University |
Neurobiology of Drug
Effects
View in PowerPoint (Size: 1.17 MB)
|
Peter Kalivas, Ph.D.
Medical Univeristy of South Carolina |
Developmental Neurobiology
Of Drug Exposure |
Bryan Kolb, Ph.D.
University of Lethbridge
Alberta, Canada |
Risk Factors and Trajectories
For Drug Abuse |
Ralph E. Tarter, Ph.D.
University of Pittsburgh |
Discussion |
Kathleen
R. Merikangas, Ph.D., Chair
Yale University |
Back to Top
II. Ongoing Treatment Studies
Treatment studies targeting various disorders, populations,
and interventions, with drug abuse and other outcome measures.
Chair: Elizabeth Robertson, Ph.D., National
Institute on Drug Abuse
Presentation Presenters
Presentation |
Presenters
|
Introduction |
David J. Kolko, Ph.D.
University of Pittsburgh |
Overview of Interventions
Research Findings
View in PowerPoint (Size: 52 KB) |
Barbara J. Burns,
Ph.D.
Duke University |
Fast Track Project |
Mark T. Greenberg,
Ph.D.
Pennsylvania State University |
Cognitive Behavior
Therapy For Anxiety Disorders |
Philip C. Kendall,
Ph.D.
Temple University |
Massachusetts General
Hospital ADHD Project |
Timothy Wilens, M.D.
Massachusetts General Hospital |
Multimodal Treatment
Study of Children with ADHD |
Peter S. Jensen, M.D.
Columbia University |
Multisystemic Therapy
Study
View in PowerPoint (Size: 66 KB)
|
Scott W. Henggeler,
Ph.D.
Medical University of South Carolina |
Panel Discussion
Research Implications |
David J. Kolko, Ph.D., Chair
Barbara J. Burns, Ph.D.
Mark T. Greenberg, Ph.D.
Scott W. Henggeler, Ph.D.
Peter S. Jensen, M.D.
Philip C. Kendall, Ph.D.
Kathleen R. Merikangas, Ph.D.
Timothy Wilens, M.D.
Kenneth C. Winters, Ph.D.
|
Back to Top
III. Methodological Challenges
A. Measuring drug abuse and related risk factors
Chair: James D. Colliver, Ph.D., National
Institute on Drug Abuse
Presentation Presenters
Presentation |
Presenters
|
Introduction to Measurement
Domains, Methods, and Instruments |
Robert Pandina, Ph.D.
Rutgers University |
Drug Use Disorders
Screening And Assessment |
Kenneth C. Winters,
Ph.D.
University of Minnesota |
Measuring Drug Use
and Key Risk, Mediating and Moderating Factors
View in PowerPoint (Size: 71 KB) |
Duncan Clark, Ph.D.,
M.D.
University of Pittsburgh |
Panel Discussion |
Robert Pandina, Ph.D., Chair
Duncan Clark, Ph.D., M.D.
Kenneth C. Winters, Ph.D.
|
B. Addressing Follow-up, Design, and Analysis Problems
Presentation |
Presenters
|
Introduction to Followup,
Design And Data Analysis Issues |
Robert Pandina, Ph.D.
Rutgers University |
Dealing With Differential
Attrition And Missing Data |
C. Henricks Brown,
Ph.D.
University of South Florida |
Nonrandom Designs,
Appropriate Controls, and Limitations of Statistical Control
View in PowerPoint (Size: 86 KB) |
Naihua Duan, Ph.D.
University of California, Los Angeles |
Panel Discussion |
Robert Pandina, Ph.D., Chair
C. Henricks Brown, Ph.D.
Naihua Duan, Ph.D.
|
Back to Top
IV. Research Implementation
Implementing studies on drug abuse and related behaviors:
sample retention, ethical and legal matters, and scientific collaboration.
Chair: Vincent Smeriglio, Ph.D., National
Institute on Drug Abuse
Presentation |
Presenters
|
Ethical Considerations
in Interventions Relevant to Mental Health and Drug Abuse
View in PowerPoint (Size: 254 KB)
|
Celia B. Fisher, Ph.D.
Fordham University |
Working With High-Risk
Populations: Sample Recruitment, Sample Retention, and Institutional
Review Board Issues |
Nancy Day, Ph.D.
University of Pittsburgh |
Conducting Multisite
Collaborative Studies: Lessons Learned and Their Implications
for Assessing the Impact of Childhood Interventions on Subsequent
Drug Abuse
View in PowerPoint (Size: 35 KB)
|
Audrey Smith Rogers,
Ph.D., M.P.H.
National Institute on Child Health and Human Development |
Panel Discussion |
Celia B. Fisher, Ph.D.
Nancy Day, Ph.D.
Audrey Smith Rogers, Ph.D., M.P.H.
|
V. Synthesis and Future Directions
Overview and Synthesis Directions for Future
Research
- Philip C. Kendall, Ph.D., Temple University
- Ronald C. Kessler, Ph.D., Harvard University
Medical School
Back to Top
|